Conn. Gen. Stat. § 4a-53c: Maximum fair prices for prescription drug purchases for health care programs subsidized by the state.

(a) As used in this section, (1) “maximum fair prices” means the prices negotiated by the Centers for Medicare and Medicaid Services for certain prescription drugs under the Inflation Reduction Act, P.L. 117-69, and (2) “drug purchasing agency” has the same meaning as provided in section 4a-53b. A drug purchasing agency may incorporate as a guiding price in the negotiations with a pharmaceutical drug manufacturer, the maximum fair prices in any negotiation with a pharmaceutical drug manufacturer to supply prescription drugs for health care programs subsidized by the state.

(b) In purchasing drugs at bulk prices pursuant to section 4a-53b or maximum fair prices pursuant to this section, a drug purchasing agency may enter into a compact with officials in other states to increase the state's purchasing power in negotiations with pharmaceutical companies. A drug purchasing agency shall consider recommendations of the council established pursuant to section 4a-53d in any negotiations for prescription drugs pursuant to this section or section 4a-53b.